1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Dorzolamide |
| brand | String | Trusopt; with timolol as Cosopt |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Carbonic_anhydrase_inhibitors|Carbonic anhydrase inhibitor (topical)]] • [[:Category:Glaucoma_medications|Glaucoma medication]] • [[:Category:Ocular_hypotensive_agents|Ocular hypotensive agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000B08-QINU`"', '"`UNIQ--vote-00000B09-QINU`"' |
| starting_dose | String | 1 drop in affected eye(s) TID (monotherapy); BID with timolol (Cosopt) |
| preparations | String | 2% ophthalmic solution (Trusopt); 2%/0.5% fixed combination with timolol (Cosopt, Cosopt PF) |
| fda_max | String | TID per eye |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical ophthalmic |
| onset | String | IOP lowering at 2 hours; max at 4 hours |
| duration | String | 8-12 hours (TID dosing needed) |
| halflife | String | ~4 months in erythrocytes (carbonic anhydrase binding in red cells; not relevant to topical IOP duration)'"`UNIQ--ref-00000B0A-QINU`"' |
| bioavailability | String | Topical with measurable systemic absorption (small CA inhibition observed clinically with chronic use)'"`UNIQ--ref-00000B0B-QINU`"' |
| pregnancy | String | Limited data; weigh against alternatives.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
